3 Recruiting Hodgkin Lymphoma Phase 1 / Phase 2 Clinical Trials

Active phase 1 / phase 2 studies for hodgkin lymphoma enrolling across the USA. Verify eligibility and contact site coordinators.

All Hodgkin Lymphoma studies

Phase 1 / Phase 2 Studies for Hodgkin Lymphoma

🔵 Active, Not Recruiting Phase1 / Phase2

A(B)VD Followed by Nivolumab as Frontline Therapy for Higher Risk Patients With Classical Hodgkin Lymphoma (HL)

📍 Karmanos Cancer Institute — Detroit, Michigan

View Study & Checklist ➔

🟢 Recruiting Phase1 / Phase2

Nivolumab With Ruxolitinib in Relapsed or Refractory Classical Hodgkin Lymphoma

📍 University of Illinois Cancer Center — Chicago, Illinois

View Study & Checklist ➔

🟢 Recruiting Phase1 / Phase2

ATLCAR.CD30.CCR4 for CD30+ HL ATLCAR.CD30.CCR4 Cells

📍 Lineberger Comprehensive Cancer Center — Chapel Hill, North Carolina

View Study & Checklist ➔